Kennedy Capital Management
MYOK

Kennedy Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Kennedy Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-22,131
Closed -$3.02M – 725
2020
Q3 		$3.02M Sell
22,131
-174
-0.8% -$18.5K 0.09% 418
2020
Q2 		$2.15M Buy
22,305
+153
+0.7% +$12.8K 0.06% 484
2020
Q1 		$1.04M Buy
+22,152
New +$1.42M 0.04% 555

Kennedy Capital Management's MYOK Position: Q4 2020 in Review

Kennedy Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 22,131 shares — an estimated $3.02M sold.

Kennedy Capital Management first reported a position in MYOK in Q1 2020 and held it in 3 quarters. The position peaked at $3.02M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Kennedy Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Kennedy Capital Management sold 22,131 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $3.02M.
  • Kennedy Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Kennedy Capital Management's MyoKardia, Inc. Common Stock position peaked at $3.02M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Kennedy Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.